US Representative

David Rouzer 2025-2026 Regular Session - Authored & Sponsored Legislation (Page 4)

Legislative Session

Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB371

Introduced
1/13/25  
No Hires for the Delinquent IRS Act This bill prohibits the hiring of additional Internal Revenue Service (IRS) employees until the Department of the Treasury publicly certifies in writing that the IRS does not employ any individual who has a seriously delinquent tax debt.The bill defines seriously delinquent tax debt as an outstanding tax debt for which a notice of lien is filed in public records, but excluding tax debtsbeing paid pursuant to an installment agreement or offer-in-compromise,for which collection action is suspended because a due process hearing or innocent spouse relief is requested,subject to levy, orreleased from levy due to economic hardship.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB372

Introduced
1/13/25  
Refer
1/13/25  
Drug Testing for Welfare Recipients ActThis bill requires states participating in the Temporary Assistance for Needy Families program, the Supplemental Nutrition Assistance Program, and specified public housing programs to subject applicants to substance abuse testing or screening and to deny benefits for individuals who test positive for a controlled substance.Specifically, states administering these programs must determine whether an adult applicant for benefits has been arrested for a drug-related offense within the past five years. Applicants who have been arrested for such an offense must be tested for at least one controlled substance and must test negative to receive benefits. Applicants who have not been arrested for such an offense must be screened (via an interview, questionnaire, or other instrument) for risk of substance abuse. Applicants determined to be at high risk for substance abuse must be tested for at least one controlled substance and must test negative to receive benefits. Applicants who are determined not to be at high risk do not have to undergo testing. Applicants who test positive for a controlled substance at any point during this process are ineligible for benefits for one year, until they complete a treatment program, or until they test negative for the substance, whichever is later. Family members and households of individuals disqualified from receiving benefits under these provisions may generally continue to receive support.States that fail to enforce these provisions are subject to reduced federal funding for these programs the following fiscal year. 
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB377

Introduced
1/14/25  
Regulation Reduction Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB465

Introduced
1/15/25  
Old Glory Only Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB470

Introduced
1/16/25  
Red Snapper Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB474

Introduced
1/16/25  
Lumbee Fairness Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB534

Introduced
1/16/25  
Refer
1/16/25  
CONTAINER Act Creating Obstructions Necessary To Address Illegal and Nefarious Entry Rapidly Act

Original Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB400

Introduced
1/14/25  
No taxpayer funding for United Nations Human Rights Council Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB472

Introduced
1/16/25  
Restore VA Accountability Act of 2025 Restore Department of Veterans Affairs Accountability Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB524

Introduced
1/16/25  
NO GOTION Act No Official Giveaways Of Taxpayers’ Income to Oppressive Nations Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB569

Introduced
1/21/25  
Birthright Citizenship Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB578

Introduced
1/21/25  
Sarah's LawThis bill requires the Department of Justice or the Department of Homeland Security (DHS) to detain a non-U.S. national (alien under federal law) who is unlawfully present in the United States and has been charged with, arrested for, convicted of, or admits to having committed acts that constitute the essential elements of a crime that resulted in the death or serious bodily injury of another person.DHS must obtain information about the identity of any victims of the crimes for which the detained individual was charged or convicted. DHS shall provide the victim, or a relative or guardian of a deceased victim, with information about the detained individual, including name, date of birth, nationality, immigration status, criminal history, and a description of any related removal efforts.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB583

Introduced
1/21/25  
Refer
1/21/25  
BEACH Act of 2025 Beaches Environmental Assessment and Coastal Health Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB599

Introduced
1/22/25  
Protect Funding for Women’s Health Care Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB685

Introduced
1/23/25  
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)